Back
Merrimack Pharmaceuticals Vs. Theriva Biologics Industry Stock Comparison
Buy
63
MACK
Merrimack Pharmaceuticals
Last Price:
15.03
Seasonality Move:
-16.2%
Sell
35
TOVX
Theriva Biologics
Last Price:
0.41
Seasonality Move:
-3.32%
Buy
63
Merrimack Pharmaceuticals (MACK)
is a Buy
Is Merrimack Pharmaceuticals a Buy, Sell or Hold?
- The current Merrimack Pharmaceuticals [MACK] share price is $15.03. The Score for MACK is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- MACK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $0.42. The Score for TOVX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- TOVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MACK Stock Price Chart
What is Merrimack Pharmaceuticals's stock price today?
-
The Merrimack Pharmaceuticals share price today is $15.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MACK is experiencing buying pressure, which is a positive indicator for future bullish movement.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $0.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing buying pressure, which is a positive indicator for future bullish movement.
MACK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 81.31 | Buy |
| Chaikin Money Flow: | 195320 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
TOVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 47.37 | Sell |
| Chaikin Money Flow: | 20409 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.41 - 0.45) | Sell |
| Bollinger Bands (100): | (0.42 - 0.52) | Sell |
MACK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.8 | Buy |
| 20-day SMA: | 14.74 | Buy |
| 50-day SMA: | 14.72 | Buy |
| 200-day SMA: | 13.2 | Buy |
| 8-day EMA: | 14.84 | Buy |
| 20-day EMA: | 14.77 | Buy |
| 50-day EMA: | 14.58 | Buy |
| 200-day EMA: | 13.35 | Buy |
TOVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.4 | Buy |
| 20-day SMA: | 0.42 | Sell |
| 50-day SMA: | 0.45 | Sell |
| 200-day SMA: | 0.5 | Sell |
| 8-day EMA: | 0.41 | Buy |
| 20-day EMA: | 0.42 | Sell |
| 50-day EMA: | 0.44 | Sell |
| 200-day EMA: | 0.54 | Sell |
Merrimack Pharmaceuticals Earnings Growth & MACK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.05 per share.
Merrimack Pharmaceuticals Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Theriva Biologics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||